APA 2013: Many Sessions to Focus on Diverse Populations

May 13, 2013

ARLINGTON, Va. (May 13, 2013) – The American Psychiatric Association’s 166th Annual Meeting, will feature a series of sessions highlighting issues relating to diverse populations, including racial and ethnic groups, immigrants, and lesbian, gay, bisexual, and transgender (LGBT) populations.

The APA meeting, the world’s largest psychiatric meeting, will run Saturday, May 18 to Wednesday, May 22, 2013 in San Francisco at the Moscone Convention Center.…

APA 2013 | Conference Coverage

New research is being presented at APA 2013, the American Psychiatric Association’s 166th annual meeting, from May 18-21 in San Francisco.
…

APA 2013: Special Research Track on Science of Addiction | Conference Coverage

ARLINGTON, Va. (May 10, 2013) – The National Institute on Drug Abuse (NIDA) and APA have collaborated to organize a special track, Advancing Psychiatric Practice Through the Science of Addiction, at the APA Annual Meeting. The APA meeting, the world’s largest psychiatric meeting, will run Saturday, May 18 to Wednesday, May 22, 2013 in San Francisco at the Moscone Convention Center.…

Hospital Medicine 2013 | Conference Coverage

New research is being presented at Hospital Medicine 2013, the annual meeting of the Society of Hospital Medicine, from May 16-19 in National Harbor, MD.…

Heart Rhythm 2013: Newer Defib Leads Safe So Far | Conference Coverage

DENVER — Newer iterations of St. Jude defibrillator leads appear to have shed the problems that led to recall of its Riata line, independent registry analysis confirmed.

Freedom from any mechanical failure was 99.4% at 5 years for the company’s Riata ST Optim and Durata leads, John Cairns, MD, of the University of British Columbia in Vancouver, and colleagues found.…

Heart Rhythm 2013: Imaging May Foretell Ablation Success | Conference Coverage

DENVER — Cardiac fibrosis measured on MRI appears to predict the success of ablation for atrial fibrillation, a study showed.

Each 1% greater fibrosis was associated with a 6% higher risk of recurrence of the arrhythmia after ablation in a multivariate model (P<0.0001), Nassir Marrouche, MD, of the University of Utah in Salt Lake City, and colleagues found.…

Heart Rhythm 2013: Continuous Warfarin Safer in Ablation | Conference Coverage

DENVER — Keeping warfarin (Coumadin) on board for an atrial fibrillation ablation procedure is safer than bridging with heparin, a randomized trial showed.

Peri-procedural thromboembolic events were nine times more common with heparin bridging than with uninterrupted warfarin after adjusting for other factors, making it a stronger predictor than even the CHADS2 risk score in the COMPARE trial (P=0.002).…

Heart Rhythm 2013: Cryoablation May Not Need Full Anesthesia | Conference Coverage

DENVER — General anesthesia may not be necessary during cryoablation procedures for atrial fibrillation, a small study suggested.

Conscious sedation with dexmedetomidine (Precedex) plus some fentanyl and midazolam (Versed) was enough to keep patients comfortable through the procedure without any recollection afterward of the painful phrenic nerve pacing involved, Patricia Gasper, RN, electrophysiology coordinator at Memorial Leighton Heart and Vascular Center in South Bend, Ind., and colleagues found.…

How to Operate on the Wrong Site | Guest Blog

Be foggy whether a time-out was performed, fault your staff, and don't re-examine the patient on the day of surgery.

SCAI 2013: SYNTAX Boosts Multivessel CAD Outcomes | Guest Blog

ORLANDO — Using the SYNTAX score to guide the choice of revascularization in patients with three-vessel coronary artery disease improves clinical outcomes, a single-center study suggested.

Compared with patients who underwent percutaneous coronary intervention (PCI) with a SYNTAX score greater than 22 (considered inappropriate), those who underwent appropriate revascularization with coronary artery bypass graft (CABG) or PCI had a significantly reduced risk of all-cause death, acute myocardial infarction (MI), or stroke (11.3% versus 25.8%, hazard ratio 0.27, 95% CI 0.15 to 0.52), according to Tonga Nfor, MD, of Aurora St.…